皓宸医疗(002622) - 2014 Q1 - 季度财报

Financial Performance - Revenue for Q1 2014 was CNY 19,913,111.35, a decrease of 29.6% compared to CNY 28,285,232.04 in the same period last year[10] - Net profit attributable to shareholders was CNY 4,086,092.52, down 14.92% from CNY 4,802,767.76 year-on-year[10] - Net cash flow from operating activities was negative CNY 8,140,315.37, a decline of 198.96% compared to positive CNY 8,226,278.46 in the previous year[10] - The net profit attributable to shareholders for the first half of 2014 is expected to decline by 48% to 21%, ranging from 10.348 million to 15.721 million yuan[22] - The net profit for the first half of 2013 was 19.90 million yuan, indicating a significant decrease in performance year-over-year[22] Assets and Equity - Total assets at the end of the reporting period were CNY 1,244,928,039.56, an increase of 0.23% from CNY 1,242,029,644.44 at the end of the previous year[10] - Net assets attributable to shareholders increased by 0.35% to CNY 1,180,341,072.51 from CNY 1,176,254,979.99 at the end of the previous year[10] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,772[13] - The top shareholder, Lv Yongxiang, holds 33.66% of the shares, totaling 50,482,600 shares[13] - The company has made commitments to shareholders regarding the transfer and management of shares, ensuring stability in shareholding[21] Operational Insights - The company reported non-operating income of CNY 254,532.80 after tax adjustments[11] - The company is actively exploring new industry clients to mitigate the impact of deteriorating conditions in traditional industry clients[22] Investment Status - There are no securities investments reported during the period, with no shares held or changes in investment status[24] Earnings Per Share - Basic and diluted earnings per share remained unchanged at CNY 0.03[10] Return on Equity - The weighted average return on equity decreased to 0.35% from 0.42% year-on-year[10]